enGene Holdings Inc.

General ticker "ENGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $403.3M (TTM average)

enGene Holdings Inc. follows the US Stock Market performance with the rate: 11.1%.

Estimated limits based on current volatility of 4.6%: low 1.75$, high 1.92$

Factors to consider:

  • Total employees count: 82 (+43.9%) as of 2025
  • Current price 63.3% below estimated low
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-10-31 to 2027-10-31

  • 2025-10-31 to 2026-10-31 estimated range: [4.74$, 12.22$]
  • 2026-10-31 to 2027-10-31 estimated range: [3.80$, 10.13$]

Financial Metrics affecting the ENGN estimates:

  • Negative: with PPE of -3.5 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Shareholder equity ratio, % of 75.73 > 64.29
  • Negative: negative Net income
  • Positive: -14.17 < Investing cash flow per share per price, % of -6.19
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0.74 <= 3.31

Similar symbols

Short-term ENGN quotes

Long-term ENGN plot with estimates

Financial data

YTD 2023-10-31 2024-10-31 2025-10-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $26.06MM $62.30MM $123.17MM
Operating Income $-26.06MM $-62.30MM $-123.17MM
Non-Operating Income $-73.84MM $7.14MM $5.86MM
Interest Expense $4.95MM $2.80MM $2.99MM
R&D Expense $16.46MM $38.31MM $94.48MM
Income(Loss) $-99.90MM $-55.16MM $-117.30MM
Taxes $0.02MM $-0.02MM $0.00MM
Net Income(Loss)* $-99.92MM $-55.14MM $-117.30MM
Stockholders Equity $72.49MM $272.61MM $167.71MM
Assets $86.96MM $311.17MM $221.47MM
Operating Cash Flow $-24.74MM $-48.28MM $-99.24MM
Capital expenditure $0.32MM $0.93MM $1.49MM
Investing Cash Flow $-0.32MM $-125.95MM $-25.14MM
Financing Cash Flow $86.15MM $265.72MM $1.52MM
Earnings Per Share** $-4.24 $-1.24 $-2.29

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.